A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

Clinical trial NCT01435863 · COMPLETED

Trial details

NCT number: NCT01435863
Sponsor: Solasia Pharma K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2011-09-01
Primary completion: 2015-04-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.